Navigation Links
ResMed Inc. Announces Record Financial Results For The Quarter Ended And Six Months Ended December 31, 2011
Date:1/26/2012

tion of acquired intangible assets

3,691

2,573

7,462

4,604Donation to Foundation

-

-

-

1,000Total operating expenses

131,461

116,126

255,641

223,687Income from operations

67,254

69,873

128,129

136,266Other income (expenses), net:Interest income (expense), net

7,181

6,005

14,103

11,102Other, net

8,496

3,043

7,196

8,106Total other income (expenses), net

15,677

9,048

21,299

19,208Income before income taxes

82,931

78,921

149,428

155,474Income taxes

20,059

20,465

36,038

40,310Net income

$62,872

$58,456

$113,390

$115,164Basic earnings per share

$0.43

$0.38

$0.76

$0.76Diluted earnings per share

$0.42

$0.37

$0.75

$0.73Basic shares outstanding

146,369

152,420

148,368

152,006Diluted shares outstanding

149,515

157,593

151,835

157,276RESMED INC AND SUBSIDIARIESCondensed Consolidated Balance Sheets (Unaudited - In US$ thousands)December 31,

June 30,2011

2011ASSETSCurrent assets:Cash and cash equivalents

$723,233

$735,267Accounts receivable, net

238,764

274,352Inventories

184,420

200,777Prepayments, deferred income taxes and other current assets

100,350

82,056Total current assets

1,246,767

1,292,452Property, plant and equipment, net

441,000

462,107Goodwill

261,109

235,487Other intangibles

61,645

47,911Deferred income taxes and other non-current assets

30,957

30,965Total non-current assets

794,711

776,470Total assets

$2,041,478

$2,068,922LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Accounts payable

45,763


'/>"/>
SOURCE ResMed Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. ResMed Announces Change to Outside US Dial-in Number for Conference Call and Webcast to Discuss Second Quarter 2012 Results
2. ResMed Announces Conference Call and Webcast to Discuss Second Quarter 2012 Results
3. ResMed Inc. Announces Financial Results for the Quarter Ended September 30, 2011
4. ResMed Announces Conference Call and Webcast to Discuss First Quarter 2012 Results
5. ResMed Inc. to Present at Upcoming Conferences
6. CareFusion and ResMed Announce Distribution Agreement for U.S. Hospital Market
7. ResMed Announces Conference Call and Webcast to Discuss Fourth Quarter and Fiscal Year End 2011 Results
8. ResMed Announces Acquisition of BiancaMed
9. ResMed Announces New iPhone App
10. ResMed Inc. Announces Record Financial Results for the Quarter Ended and Nine Months Ended March 31, 2011
11. The Next Generation in Bilevel Therapy Now Available on ResMeds Award-Winning S9™ Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... nebulizer is a medical device used for the treatment ... converts liquid medication into mist or aerosol. Thus, the ... patient when inhaled through the mouth or a face ... devices powered by electric current and rechargeable batteries. Factors ... fibrosis and growing number of geriatric population worldwide support ...
(Date:10/30/2014)... 2014 CTI BioPharma Corp. (CTI) (NASDAQ and MTA: ... September 30, 2014. "During the quarter, ... beginning of 2014 by securing a partner to accelerate the ... market into countries where we do not have a commercial ... this partnership will maximize the value of PIXUVRI for CTI ...
(Date:10/30/2014)... 2014 Today Eli Lilly and Company (NYSE: ... technology transfer program to increase the global supply of ... effort included Lilly donating manufacturing technology and know-how for ... , India , ... – all MDR-TB ,hot spots., It also served ...
Breaking Medicine Technology:Nebulizers Market (Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 2Nebulizers Market (Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 3CTI BioPharma Reports Third Quarter 2014 Financial Results 2CTI BioPharma Reports Third Quarter 2014 Financial Results 3CTI BioPharma Reports Third Quarter 2014 Financial Results 4CTI BioPharma Reports Third Quarter 2014 Financial Results 5CTI BioPharma Reports Third Quarter 2014 Financial Results 6CTI BioPharma Reports Third Quarter 2014 Financial Results 7CTI BioPharma Reports Third Quarter 2014 Financial Results 8CTI BioPharma Reports Third Quarter 2014 Financial Results 9CTI BioPharma Reports Third Quarter 2014 Financial Results 10CTI BioPharma Reports Third Quarter 2014 Financial Results 11CTI BioPharma Reports Third Quarter 2014 Financial Results 12Lilly Shares Insights from Decade-Long Technology Transfer Experience 2Lilly Shares Insights from Decade-Long Technology Transfer Experience 3Lilly Shares Insights from Decade-Long Technology Transfer Experience 4
... - Introgen,Therapeutics, Inc. (NASDAQ:INGN) today announced the publication ... survival,pathway impacts the anticancer activity of INGN 241. ... tumor killing effects of,INGN 241 in cell culture ... Introgen and The University of Texas M. D. ...
... 2007 - Genmab A/S (CSE: GEN),announced today that ... (HuMax-CD20™) in patients with rheumatoid,arthritis (RA) have been ... Congress of Rheumatology (EULAR). The oral,presentation, which will ... II study with ofatumumab, along with data,from the ...
Cached Medicine Technology:Preclinical Studies Identify Novel Approach for Enhancing the,Anticancer Activity of Introgen's INGN 241 2Preclinical Studies Identify Novel Approach for Enhancing the,Anticancer Activity of Introgen's INGN 241 3
(Date:10/30/2014)... Dr. Joseph Furlin MD, a certified obstetrician and gynecologist, has ... GYN in Melrose Park, IL and OB GYN ... about each of the care services and practice areas that ... and Spanish. The navigation of the website is easy ... Dr. Furlin’s patients with important information regarding his care methods ...
(Date:10/30/2014)... October 30, 2014 REV'D Provision Co. ... now available through a unique service called, The ... to empower the everyday athlete. The Feed has taken ... and created a system to pass that information on ... REV’D® is now available on The Feed!” says REV’D® ...
(Date:10/30/2014)... October 30, 2014 Sound Telecom, a leader ... that will assist people any time they wonder, “Should I ... right answer by leading them through a series of yes ... their initial query. , There are many considerations and scenarios ... use an answering service . This decision infographic serves ...
(Date:10/30/2014)... HealthDay Reporter WEDNESDAY, Oct. ... be bad for your health, a new study reports. ... help strengthen bones and prevent osteoporosis. These benefits to bone ... part of a healthy diet. But this new study ... men or women from bone fractures, and was linked to ...
(Date:10/30/2014)... new vaccine that could help prevent some cases of ... Food and Drug Administration on Wednesday. Trumenba is ... and 25 from invasive meningococcal disease caused by ... can infect the bloodstream (sepsis) and the lining that ... leading cause of bacterial meningitis, and infection can occur ...
Breaking Medicine News(10 mins):Health News:Dr. Joseph Furlin Launches New Website with Information about Care Services 2Health News:Nutrition Experts at TheFeed.com Get REV'D 2Health News:Nutrition Experts at TheFeed.com Get REV'D 3Health News:Sound Telecom Produces Decision Infographic to Aid Businesses 2Health News:Is Milk Your Friend or Foe? 2Health News:Is Milk Your Friend or Foe? 3Health News:FDA Approves New Vaccine to Protect Against Meningitis 2
... day to analysis and expert thought, they may be able ... of the precise type of brain tumour they face. Now ... technique that can give a preliminary analysis of the precise ... the brain and nervous system and they account for 20% ...
... Rosemont, Ill. - June 17, 2008- Current protein recommendations ... newer research indicates that many adults may benefit from ... presented in a supplement in the May issue of ... describing the conclusions of a Protein Summit ...
... on invasion and migration in colorectal cancer cell line. This ... performed by a team led by Professor Ji-Kun Li from ... article to be published on April 21, 2008 in the ... of the main causes of cancer-related death in the world. ...
... 17 XTENT, Inc.,(Nasdaq: XTNT ) today announced ... the current issue of EuroIntervention was recognized by the,journal,s ... submitted to the,journal this past winter. Lutz Buellesfeld, M.D., ... of the study,s investigators, received,an award in conjunction with ...
... Ala., June 17 Emageon Inc.,(Nasdaq: EMAG ... for hospitals, healthcare networks and imaging facilities announced,today ... present at the,Jefferies 2nd Annual Healthcare Conference on ... 24th at 8:30 AM ET. The presentation will ...
... 17 Nutrition 21, Inc.,(Nasdaq: NXXI ), ... consumers manage blood sugar levels, improve cardiovascular health,enhance ... Skin,Rejuvenation(TM) a new Iceland Health-branded product. Skin Rejuvenation ... capsule form,designed to reduce, at the cellular level, ...
Cached Medicine News:Health News:Wavelets crunch through doctors' day long struggle to diagnose brain tumors 2Health News:Is it time to revisit the current protein recommendations? 2Health News:Is it time to revisit the current protein recommendations? 3Health News:XTENT Announces CUSTOM I Data Receives Recognition from EuroIntervention 2Health News:XTENT Announces CUSTOM I Data Receives Recognition from EuroIntervention 3Health News:Nutrition 21 Introduces New Product: Iceland Health Skin Rejuvenation(TM) 2Health News:Nutrition 21 Introduces New Product: Iceland Health Skin Rejuvenation(TM) 3
Adhesive tape sheets for sealing multiwell plates and blocks;...
Microwell Plate Accessories...
DMSO-resistant microplate sealing film...
Amplification Tape 96 featuring 3M adhesive technology. Good optical quality. Minimal autofluorescence. Certified RNase and DNase free....
Medicine Products: